㈱セルージョン
1 known investors
Cellusion is a Japanese biotech company developing cell-based therapies for corneal disease, including a corneal endothelial cell substitute derived from induced pluripotent stem (iPS) cells. It focuses on regenerative medicine to treat patients with corneal endothelial dysfunction.
Founders & leadership
SH
Shin HatouCEO
Investors · 1
Frequently asked questions
- What does ㈱セルージョン do?
- Cellusion is a Japanese biotech company developing cell-based therapies for corneal disease, including a corneal endothelial cell substitute derived from induced pluripotent stem (iPS) cells. It focuses on regenerative medicine to treat patients with corneal endothelial dysfunction.
- Who are ㈱セルージョン's investors?
- ㈱セルージョン's investors include DBJ Capital.